Oncolytics Biotech
ONCY
#9071
Rank
HK$0.95 B
Marketcap
HK$8.84
Share price
6.60%
Change (1 day)
60.25%
Change (1 year)

Oncolytics Biotech (ONCY) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : HK$83.95 Million

According to Oncolytics Biotech 's latest financial reports the company's total liabilities are HK$83.95 Million. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Oncolytics Biotech - Total liabilities on balance sheet (from 2001 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31HK$76.84 M15.93%
2023-12-31HK$66.28 M6.28%
2022-12-31HK$62.37 M4.22%
2021-12-31HK$59.84 M2.61%
2020-12-31HK$58.32 M-50.52%
2019-12-31HK$0.11 B136.48%
2018-12-31HK$49.84 M-18.71%
2017-12-31HK$61.31 M161.16%
2016-12-31HK$23.47 M55.08%
2015-12-31HK$15.13 M-32.87%
2014-12-31HK$22.55 M-48.48%
2013-12-31HK$43.77 M-22.99%
2012-12-31HK$56.83 M14.44%
2011-12-31HK$49.66 M155.1%
2010-12-31HK$19.46 M-37.5%
2009-12-31HK$31.14 M8.09%
2008-12-31HK$28.81 M30.68%
2007-12-31HK$22.05 M19.32%
2006-12-31HK$18.47 M50.61%
2005-12-31HK$12.26 M72.52%
2004-12-31HK$7.11 M15.01%
2003-12-31HK$6.18 M-11.19%
2002-12-31HK$6.96 M-54.38%
2001-12-31HK$15.26 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Eli Lilly
LLY
HK$672.30 B 800,729.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
HK$559.58 B 666,461.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Mirati Therapeutics
MRTX
HK$1.43 B 1,607.52%๐Ÿ‡บ๐Ÿ‡ธ USA
Aeterna Zentaris
AEZS
HK$0.18 B 121.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
HK$256.85 B 305,859.09%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
AVEO Oncology
AVEO
HK$0.56 B 574.54%๐Ÿ‡บ๐Ÿ‡ธ USA